Cargando…
Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001
STRO-001 is a site-specific, predominantly single-species, fully human, aglycosylated anti-CD74 antibody-drug conjugate incorporating a non-cleavable linker-maytansinoid warhead with a drug-antibody ratio of 2 which was produced by a novel cell-free antibody synthesis platform. We examined the poten...
Autores principales: | Abrahams, Cristina L., Li, Xiaofan, Embry, Millicent, Yu, Abigail, Krimm, Stellanie, Krueger, Sarah, Greenland, Nancy Y., Wen, Kwun Wah, Jones, Chris, DeAlmeida, Venita, Solis, Willy A., Matheny, Shannon, Kline, Toni, Yam, Alice Y., Stafford, Ryan, Wiita, Arun P., Hallam, Trevor, Lupher, Mark, Molina, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340874/ https://www.ncbi.nlm.nih.gov/pubmed/30701025 http://dx.doi.org/10.18632/oncotarget.26491 |
Ejemplares similares
-
Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001
por: Li, Xiaofan, et al.
Publicado: (2023) -
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers
por: Li, Xiaofan, et al.
Publicado: (2023) -
Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia
por: Le, Quy, et al.
Publicado: (2023) -
Localization and Characterization of STRO-1(+) Cells in the Deer Pedicle and Regenerating Antler
por: Rolf, Hans J., et al.
Publicado: (2008) -
Protein Expression of STRO-1 Cells in Response to Different Topographic Features
por: Kantawong, Fahsai, et al.
Publicado: (2011)